Federated Hermes’s Apollo Endosurgery, Inc. APEN Stock Holding History

Federated Hermes’s Portfolio APEN Stock Details APEN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-721,000	Closed	-$7.15M	–	2273
2023 Q1	$7.15M	Buy	721,000 +413,000	+134%	+$4.09M	0.02%	625
2022 Q4	$3.07M	Buy	+308,000	New	+$2.3M	0.01%	794
2022 Q1	–	Sell	-489	Closed	-$4K	–	2371
2021 Q4	$4K	Buy	489 +207	+73%	+$1.81K	﹤0.01%	2020
2021 Q3	$3K	Buy	282 +160	+131%	+$1.38K	﹤0.01%	2080
2021 Q2	$1K	Buy	+122	New	+$837	﹤0.01%	2179

Federated Hermes's APEN Position: Q2 2023 in Review

Federated Hermes sold out of Apollo Endosurgery, Inc. (APEN) in Q2 2023, closing a stake of 721,000 shares — an estimated $7.15M sold.

Federated Hermes first reported a position in APEN in Q2 2021 and held it in 5 quarters. The position peaked at $7.15M in Q1 2023. 0 funds tracked by Wall St. Rank hold APEN as of Q2 2023.

Federated Hermes reported no remaining Apollo Endosurgery, Inc. position as of Q2 2023 after selling out during the quarter.
Federated Hermes sold 721,000 Apollo Endosurgery, Inc. shares in Q2 2023, an estimated $7.15M.
Federated Hermes first reported a position in Apollo Endosurgery, Inc. in Q2 2021 and held it in 5 quarters.
Federated Hermes's Apollo Endosurgery, Inc. position peaked at $7.15M in Q1 2023.
0 funds tracked by Wall St. Rank held Apollo Endosurgery, Inc. as of Q2 2023.

Based on Federated Hermes's 13F filing for Q2 2023, filed 14 Aug 2023.